{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:56:47Z","timestamp":1789999007737,"version":"4.0.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T00:00:00Z","timestamp":1311638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2210-11-8","type":"journal-article","created":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T06:14:27Z","timestamp":1311747267000},"source":"Crossref","is-referenced-by-count":10,"title":["Dexamethasone restrains ongoing expression of interleukin-23p19 in peripheral blood-derived human macrophages"],"prefix":"10.1186","volume":"11","author":[{"given":"Linda","family":"Palma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Sfara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,26]]},"reference":[{"key":"899_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","volume":"13","author":"B Oppmann","year":"2000","unstructured":"Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, et al.: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000, 13: 715-725. 10.1016\/S1074-7613(00)00070-4.","journal-title":"Immunity"},{"key":"899_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nri1648","volume":"5","author":"CA Hunter","year":"2005","unstructured":"Hunter CA: New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol. 2005, 5: 521-531. 10.1038\/nri1648.","journal-title":"Nat Rev Immunol"},{"key":"899_CR3","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.molimm.2006.09.001","volume":"44","author":"Z Waibler","year":"2007","unstructured":"Waibler Z, Kalinke U, Will J, Juan MH, Pfeilschifter JM, Radeke HH: TLR-ligand stimulated interleukin-23 subunit expression and assembly is regulated differentially in murine plasmacytoid and myeloid dendritic cells. Mol Immunol. 2007, 44: 1483-1489. 10.1016\/j.molimm.2006.09.001.","journal-title":"Mol Immunol"},{"key":"899_CR4","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.4049\/jimmunol.181.7.5120","volume":"181","author":"RE Roses","year":"2008","unstructured":"Roses RE, Xu S, Xu M, Koldovsky U, Koski G, Czerniecki BJ: Differential Production of IL-23 and IL-12 by Myeloid-Derived Dendritic Cells in Response to TLR Agonists. J Immunol. 2008, 181: 5120-5127.","journal-title":"J Immunol"},{"key":"899_CR5","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","volume":"168","author":"C Parham","year":"2002","unstructured":"Parham C, Chirica M, Timans J, Vaisberg E, Travis M, Cheung J, Pflanz S, Zhang R, Singh KP, Vega F, et al.: A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12R{beta}1 and a Novel Cytokine Receptor Subunit, IL-23R. J Immunol. 2002, 168: 5699-5708.","journal-title":"J Immunol"},{"key":"899_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.it.2005.10.003","volume":"27","author":"BS McKenzie","year":"2006","unstructured":"McKenzie BS, Kastelein RA, Cua DJ: Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 2006, 27: 17-23. 10.1016\/j.it.2005.10.003.","journal-title":"Trends Immunol"},{"key":"899_CR7","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1074\/jbc.M207577200","volume":"278","author":"S Aggarwal","year":"2003","unstructured":"Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL: Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem. 2003, 278: 1910-1914. 10.1074\/jbc.M207577200.","journal-title":"J Biol Chem"},{"key":"899_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005, 201: 233-240. 10.1084\/jem.20041257.","journal-title":"J Exp Med"},{"key":"899_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","volume":"24","author":"M Veldhoen","year":"2006","unstructured":"Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B: TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006, 24: 179-189. 10.1016\/j.immuni.2006.01.001.","journal-title":"Immunity"},{"key":"899_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.immuni.2008.03.001","volume":"28","author":"MJ McGeachy","year":"2008","unstructured":"McGeachy MJ, Cua DJ: Th17 cell differentiation: the long and winding road. Immunity. 2008, 28: 445-453. 10.1016\/j.immuni.2008.03.001.","journal-title":"Immunity"},{"key":"899_CR11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nature01355","volume":"421","author":"DJ Cua","year":"2003","unstructured":"Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T, et al.: Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003, 421: 744-748. 10.1038\/nature01355.","journal-title":"Nature"},{"key":"899_CR12","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1084\/jem.20030896","volume":"198","author":"CA Murphy","year":"2003","unstructured":"Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, Sedgwick JD, Cua DJ: Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med. 2003, 198: 1951-1957. 10.1084\/jem.20030896.","journal-title":"J Exp Med"},{"key":"899_CR13","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1172\/JCI21404","volume":"116","author":"D Yen","year":"2006","unstructured":"Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, Kleinschek MA, Owyang A, Mattson J, Blumenschein W, et al.: IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest. 2006, 116: 1310-1316. 10.1172\/JCI21404.","journal-title":"J Clin Invest"},{"key":"899_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cyto.2007.09.014","volume":"41","author":"E Lubberts","year":"2008","unstructured":"Lubberts E: IL-17\/Th17 targeting: on the road to prevent chronic destructive arthritis?. Cytokine. 2008, 41: 84-91. 10.1016\/j.cyto.2007.09.014.","journal-title":"Cytokine"},{"key":"899_CR15","doi-asserted-by":"publisher","first-page":"7768","DOI":"10.4049\/jimmunol.176.12.7768","volume":"176","author":"A Vaknin-Dembinsky","year":"2006","unstructured":"Vaknin-Dembinsky A, Balashov K, Weiner HL: IL-23 Is Increased in Dendritic Cells in Multiple Sclerosis and Down-Regulation of IL-23 by Antisense Oligos Increases Dendritic Cell IL-10 Production. J Immunol. 2006, 176: 7768-7774.","journal-title":"J Immunol"},{"key":"899_CR16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/brain\/awl273","volume":"130","author":"Y Li","year":"2007","unstructured":"Li Y, Chu N, Hu A, Gran B, Rostami A, Zhang GX: Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia. Brain. 2007, 130: 490-501. 10.1093\/brain\/awl273.","journal-title":"Brain"},{"key":"899_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1084\/jem.20030451","volume":"199","author":"E Lee","year":"2004","unstructured":"Lee E, Trepicchio WL, Oestreicher JL, Pittman D, Wang F, Chamian F, Dhodapkar M, Krueger JG: Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med. 2004, 199: 125-130.","journal-title":"J Exp Med"},{"key":"899_CR18","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1126\/science.1135245","volume":"314","author":"RH Duerr","year":"2006","unstructured":"Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, et al.: A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006, 314: 1461-1463. 10.1126\/science.1135245.","journal-title":"Science"},{"key":"899_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/00054725-200501000-00003","volume":"11","author":"C Schmidt","year":"2005","unstructured":"Schmidt C, Giese T, Ludwig B, Mueller-Molaian I, Marth T, Zeuzem S, Meuer SC, Stallmach A: Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis. Inflamm Bowel Dis. 2005, 11: 16-23.","journal-title":"Inflamm Bowel Dis"},{"key":"899_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature04808","volume":"442","author":"JL Langowski","year":"2006","unstructured":"Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, Smith K, Basham B, McClanahan T, Kastelein RA, Oft M: IL-23 promotes tumour incidence and growth. Nature. 2006, 442: 461-465. 10.1038\/nature04808.","journal-title":"Nature"},{"key":"899_CR21","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"T Rhen","year":"2005","unstructured":"Rhen T, Cidlowski JA: Antiinflammatory Action of Glucocorticoids -- New Mechanisms for Old Drugs. N Engl J Med. 2005, 353: 1711-1723. 10.1056\/NEJMra050541.","journal-title":"N Engl J Med"},{"key":"899_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1513\/pats.200402-001MS","volume":"1","author":"IM Adcock","year":"2004","unstructured":"Adcock IM, Ito K, Barnes PJ: Glucocorticoids: Effects on Gene Transcription. Proc Am Thorac Soc. 2004, 1: 247-254. 10.1513\/pats.200402-001MS.","journal-title":"Proc Am Thorac Soc"},{"key":"899_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/sj.bjp.0706736","volume":"148","author":"PJ Barnes","year":"2006","unstructured":"Barnes PJ: How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol. 2006, 148: 245-254.","journal-title":"Br J Pharmacol"},{"key":"899_CR24","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1124\/mol.107.038794","volume":"72","author":"R Newton","year":"2007","unstructured":"Newton R, Holden NS: Separating Transrepression and Transactivation: A Distressing Divorce for the Glucocorticoid Receptor?. Molecular Pharmacology. 2007, 72: 799-809. 10.1124\/mol.107.038794.","journal-title":"Molecular Pharmacology"},{"key":"899_CR25","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ejphar.2007.11.076","volume":"583","author":"K De Bosscher","year":"2008","unstructured":"De Bosscher K, Van Craenenbroeck K, Meijer OC, Haegeman G: Selective transrepression versus transactivation mechanisms by glucocorticoid receptor modulators in stress and immune systems. Eur J Pharmacol. 2008, 583: 290-302. 10.1016\/j.ejphar.2007.11.076.","journal-title":"Eur J Pharmacol"},{"key":"899_CR26","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/S0140-6736(09)60326-3","volume":"373","author":"PJ Barnes","year":"2009","unstructured":"Barnes PJ, Adcock IM: Glucocorticoid resistance in inflammatory diseases. The Lancet. 2009, 373: 1905-1917. 10.1016\/S0140-6736(09)60326-3.","journal-title":"The Lancet"},{"key":"899_CR27","volume-title":"Pediatric pharmacology therapeutic principles in practice","author":"SJ Yaffe","year":"1992","unstructured":"Yaffe SJ, Aranda JV: Pediatric pharmacology therapeutic principles in practice. 1992, Philadelphia: Saunders"},{"key":"899_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1189\/jlb.0605296","volume":"80","author":"AJ Fahey","year":"2006","unstructured":"Fahey AJ, Robins RA, Kindle KB, Heery DM, Constantinescu CS: Effects of glucocorticoids on STAT4 activation in human T cells are stimulus-dependent. J Leukoc Biol. 2006, 80: 133-144. 10.1189\/jlb.0605296.","journal-title":"J Leukoc Biol"},{"key":"899_CR29","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4049\/jimmunol.172.1.318","volume":"172","author":"W Ma","year":"2004","unstructured":"Ma W, Gee K, Lim W, Chambers K, Angel JB, Kozlowski M, Kumar A: Dexamethasone Inhibits IL-12p40 Production in Lipopolysaccharide-Stimulated Human Monocytic Cells by Down-Regulating the Activity of c-Jun N-Terminal Kinase, the Activation Protein-1, and NF-{kappa}B Transcription Factors. J Immunol. 2004, 172: 318-330.","journal-title":"J Immunol"},{"key":"899_CR30","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.4049\/jimmunol.177.7.4550","volume":"177","author":"M Utsugi","year":"2006","unstructured":"Utsugi M, Dobashi K, Ishizuka T, Kawata T, Hisada T, Shimizu Y, Ono A, Mori M: Rac1 negatively regulates lipopolysaccharide-induced IL-23 p19 expression in human macrophages and dendritic cells and NF-kappaB p65 trans activation plays a novel role. J Immunol. 2006, 177: 4550-4557.","journal-title":"J Immunol"},{"key":"899_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexmp.2007.09.004","volume":"84","author":"Y Li","year":"2008","unstructured":"Li Y, Chu N, Hu A, Gran B, Rostami A, Zhang GX: Inducible IL-23p19 expression in human microglia via p38 MAPK and NF-kappaB signal pathways. Exp Mol Pathol. 2008, 84: 1-8. 10.1016\/j.yexmp.2007.09.004.","journal-title":"Exp Mol Pathol"},{"key":"899_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cyto.2008.04.003","volume":"43","author":"ZG Dobreva","year":"2008","unstructured":"Dobreva ZG, Stanilova SA, Miteva LD: Differences in the inducible gene expression and protein production of IL-12p40, IL-12p70 and IL-23: involvement of p38 and JNK kinase pathways. Cytokine. 2008, 43: 76-82. 10.1016\/j.cyto.2008.04.003.","journal-title":"Cytokine"},{"key":"899_CR33","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1021\/nn100057c","volume":"4","author":"R Crinelli","year":"2010","unstructured":"Crinelli R, Carloni E, Menotta M, Giacomini E, Bianchi M, Ambrosi G, Giorgi L, Magnani M: Oxidized ultrashort nanotubes as carbon scaffolds for the construction of cell-penetrating NF-kappaB decoy molecules. ACS Nano. 2010, 4: 2791-2803. 10.1021\/nn100057c.","journal-title":"ACS Nano"},{"key":"899_CR34","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1128\/MCB.21.3.771-780.2001","volume":"21","author":"M Lasa","year":"2001","unstructured":"Lasa M, Brook M, Saklatvala J, Clark AR: Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol Cell Biol. 2001, 21: 771-780. 10.1128\/MCB.21.3.771-780.2001.","journal-title":"Mol Cell Biol"},{"key":"899_CR35","doi-asserted-by":"publisher","first-page":"9126","DOI":"10.1128\/MCB.00679-06","volume":"26","author":"K Smoak","year":"2006","unstructured":"Smoak K, Cidlowski JA: Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory signaling. Mol Cell Biol. 2006, 26: 9126-9135. 10.1128\/MCB.00679-06.","journal-title":"Mol Cell Biol"},{"key":"899_CR36","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1038\/emboj.2008.95","volume":"27","author":"IM Beck","year":"2008","unstructured":"Beck IM, Vanden Berghe W, Vermeulen L, Bougarne N, Vander Cruyssen B, Haegeman G, De Bosscher K: Altered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF-kappaB inhibition. EMBO J. 2008, 27: 1682-1693. 10.1038\/emboj.2008.95.","journal-title":"EMBO J"},{"key":"899_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1006\/bcmd.2000.0298","volume":"26","author":"R Crinelli","year":"2000","unstructured":"Crinelli R, Antonelli A, Bianchi M, Gentilini L, Scaramucci S, Magnani M: Selective inhibition of NF-kB activation and TNF-alpha production in macrophages by red blood cell-mediated delivery of dexamethasone. Blood Cells Mol Dis. 2000, 26: 211-222. 10.1006\/bcmd.2000.0298.","journal-title":"Blood Cells Mol Dis"},{"key":"899_CR38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1006\/bbrc.1997.6307","volume":"232","author":"G Baughman","year":"1997","unstructured":"Baughman G, Wiederrecht GJ, Chang F, Martin MM, Bourgeois S: Tissue distribution and abundance of human FKBP51, and FK506-binding protein that can mediate calcineurin inhibition. Biochem Biophys Res Commun. 1997, 232: 437-443. 10.1006\/bbrc.1997.6307.","journal-title":"Biochem Biophys Res Commun"},{"key":"899_CR39","volume-title":"Red blood cells as glucocorticoids delivery system. In Erythrocytes as drug carriers in medicine","author":"M D'Ascenzo","year":"1997","unstructured":"D'Ascenzo M, Antonelli A, Chiarantini L, Mancini U, Magnani M: Red blood cells as glucocorticoids delivery system. In Erythrocytes as drug carriers in medicine. Edited by: Sprandel U, Way JL. 1997, New York: Plenum Press"},{"key":"899_CR40","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.addr.2007.08.029","volume":"60","author":"F Pierig\u00e8","year":"2008","unstructured":"Pierig\u00e8 F, Serafini S, Rossi L, Magnani M: Cell-based drug delivery. Adv Drug Deliv Rev. 2008, 60: 286-295. 10.1016\/j.addr.2007.08.029.","journal-title":"Adv Drug Deliv Rev"},{"key":"899_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0165-5728(00)00297-6","volume":"109","author":"K De Bosscher","year":"2000","unstructured":"De Bosscher K, Vanden Berghe W, Haegeman G: Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. Journal of Neuroimmunology. 2000, 109: 16-22. 10.1016\/S0165-5728(00)00297-6.","journal-title":"Journal of Neuroimmunology"},{"key":"899_CR42","doi-asserted-by":"publisher","first-page":"13504","DOI":"10.1073\/pnas.94.25.13504","volume":"94","author":"K De Bosscher","year":"1997","unstructured":"De Bosscher K, Schmitz ML, Vanden Berghe W, Plaisance S, Fiers W, Haegeman G: Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci USA. 1997, 94: 13504-13509. 10.1073\/pnas.94.25.13504.","journal-title":"Proc Natl Acad Sci USA"},{"key":"899_CR43","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1093\/emboj\/16.15.4698","volume":"16","author":"S Heck","year":"1997","unstructured":"Heck S, Bender K, Kullmann M, Gottlicher M, Herrlich P, Cato AC: I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor. EMBO J. 1997, 16: 4698-4707. 10.1093\/emboj\/16.15.4698.","journal-title":"EMBO J"},{"key":"899_CR44","doi-asserted-by":"publisher","first-page":"R384","DOI":"10.1186\/ar1204","volume":"6","author":"J Westra","year":"2004","unstructured":"Westra J, Doornbos-van der Meer B, de Boer P, van Leeuwen MA, van Rijswijk MH, Limburg PC: Strong inhibition of TNF-alpha production and inhibition of IL-8 and COX-2 mRNA expression in monocyte-derived macrophages by RWJ 67657, a p38 mitogen-activated protein kinase (MAPK) inhibitor. Arthritis Res Ther. 2004, 6: R384-R392. 10.1186\/ar1204.","journal-title":"Arthritis Res Ther"},{"key":"899_CR45","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1124\/jpet.107.127092","volume":"324","author":"S Medicherla","year":"2008","unstructured":"Medicherla S, Fitzgerald MF, Spicer D, Woodman P, Ma JY, Kapoun AM, Chakravarty S, Dugar S, Protter AA, Higgins LS: p38alpha-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation. J Pharmacol Exp Ther. 2008, 324: 921-929.","journal-title":"J Pharmacol Exp Ther"},{"key":"899_CR46","doi-asserted-by":"publisher","first-page":"30858","DOI":"10.1074\/jbc.274.43.30858","volume":"274","author":"AB Carter","year":"1999","unstructured":"Carter AB, Knudtson KL, Monick MM, Hunninghake GW: The p38 Mitogen-activated Protein Kinase Is Required for NF-kappaB-dependent Gene Expression. Journal of Biological Chemistry. 1999, 274: 30858-30863. 10.1074\/jbc.274.43.30858.","journal-title":"Journal of Biological Chemistry"},{"key":"899_CR47","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1042\/bst0300952","volume":"30","author":"T Zhang","year":"2002","unstructured":"Zhang T, Kruys V, Huez G, Gueydan C: AU-rich element-mediated translational control: complexity and multiple activities of trans-activating factors. Biochem Soc Trans. 2002, 30: 952-958.","journal-title":"Biochem Soc Trans"},{"key":"899_CR48","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.cellsig.2004.04.006","volume":"16","author":"JL Dean","year":"2004","unstructured":"Dean JL, Sully G, Clark AR, Saklatvala J: The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell Signal. 2004, 16: 1113-1121. 10.1016\/j.cellsig.2004.04.006.","journal-title":"Cell Signal"},{"key":"899_CR49","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/j.febslet.2009.04.039","volume":"583","author":"C Tudor","year":"2009","unstructured":"Tudor C, Marchese FP, Hitti E, Aubareda A, Rawlinson L, Gaestel M, Blackshear PJ, Clark AR, Saklatvala J, Dean JL: The p38 MAPK pathway inhibits tristetraprolin-directed decay of interleukin-10 and pro-inflammatory mediator mRNAs in murine macrophages. FEBS Lett. 2009, 583: 1933-1938. 10.1016\/j.febslet.2009.04.039.","journal-title":"FEBS Lett"},{"key":"899_CR50","doi-asserted-by":"publisher","first-page":"4426","DOI":"10.1093\/emboj\/17.15.4426","volume":"17","author":"M Deak","year":"1998","unstructured":"Deak M, Clifton AD, Lucocq LM, Alessi DR: Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2\/p38, and may mediate activation of CREB. EMBO J. 1998, 17: 4426-4441. 10.1093\/emboj\/17.15.4426.","journal-title":"EMBO J"},{"key":"899_CR51","doi-asserted-by":"publisher","first-page":"7108","DOI":"10.1093\/emboj\/20.24.7108","volume":"20","author":"O Kassel","year":"2001","unstructured":"Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M, Cato AC: Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 2001, 20: 7108-7116. 10.1093\/emboj\/20.24.7108.","journal-title":"EMBO J"},{"key":"899_CR52","doi-asserted-by":"publisher","first-page":"7802","DOI":"10.1128\/MCB.22.22.7802-7811.2002","volume":"22","author":"M Lasa","year":"2002","unstructured":"Lasa M, Abraham SM, Boucheron C, Saklatvala J, Clark AR: Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol. 2002, 22: 7802-7811. 10.1128\/MCB.22.22.7802-7811.2002.","journal-title":"Mol Cell Biol"},{"key":"899_CR53","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1165\/rcmb.2003-0295OC","volume":"30","author":"MW Bergmann","year":"2004","unstructured":"Bergmann MW, Staples KJ, Smith SJ, Barnes PJ, Newton R: Glucocorticoid Inhibition of Granulocyte Macrophage-Colony-Stimulating Factor from T cells Is Independent of Control by Nuclear Factor-{kappa}B and Conserved Lymphokine Element 0. Am J Respir Cell Mol Biol. 2004, 30: 555-563.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"899_CR54","doi-asserted-by":"publisher","first-page":"5342","DOI":"10.4049\/jimmunol.168.10.5342","volume":"168","author":"GH Waetzig","year":"2002","unstructured":"Waetzig GH, Seegert D, Rosenstiel P, Nikolaus S, Schreiber S: p38 Mitogen-Activated Protein Kinase Is Activated and Linked to TNF-{alpha} Signaling in Inflammatory Bowel Disease. J Immunol. 2002, 168: 5342-5351.","journal-title":"J Immunol"},{"key":"899_CR55","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/nature09283","volume":"466","author":"P Rao","year":"2010","unstructured":"Rao P, Hayden MS, Long M, Scott ML, West AP, Zhang D, Oeckinghaus A, Lynch C, Hoffmann A, Baltimore D, et al.: IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response. Nature. 2010, 466: 1115-1119. 10.1038\/nature09283.","journal-title":"Nature"},{"key":"899_CR56","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1084\/jem.20071258","volume":"205","author":"D Luger","year":"2008","unstructured":"Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, Bowman EP, Sgambellone NM, Chan CC, Caspi RR: Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med. 2008, 205: 799-810. 10.1084\/jem.20071258.","journal-title":"J Exp Med"},{"key":"899_CR57","doi-asserted-by":"publisher","first-page":"25765","DOI":"10.1074\/jbc.R700053200","volume":"283","author":"AR Clark","year":"2008","unstructured":"Clark AR, Martins JRS, Tchen CR: Role of Dual Specificity Phosphatases in Biological Responses to Glucocorticoids. Journal of Biological Chemistry. 2008, 283: 25765-25769. 10.1074\/jbc.R700053200.","journal-title":"Journal of Biological Chemistry"},{"key":"899_CR58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11010-009-0146-x","volume":"331","author":"L Palma","year":"2009","unstructured":"Palma L, Crinelli R, Bianchi M, Magnani M: De-ubiquitylation is the most critical step in the ubiquitin-mediated homeostatic control of the NF-kappaB\/IKK basal activity. Mol Cell Biochem. 2009, 331: 69-80. 10.1007\/s11010-009-0146-x.","journal-title":"Mol Cell Biochem"},{"key":"899_CR59","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem. 1951, 193: 265-275.","journal-title":"J Biol Chem"},{"key":"899_CR60","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72: 248-254. 10.1016\/0003-2697(76)90527-3.","journal-title":"Anal Biochem"}],"container-title":["BMC Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2210-11-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2210-11-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2210-11-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:32:04Z","timestamp":1638145924000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1186\/1471-2210-11-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,26]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["899"],"URL":"https:\/\/doi.org\/10.1186\/1471-2210-11-8","relation":{},"ISSN":["1471-2210"],"issn-type":[{"value":"1471-2210","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,26]]},"article-number":"8"}}